PATENT CLAIM ANALYSIS

Application Number: 15947192
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["435", "006110"]

Abstract:
The present invention relates to methods for predicting, diagnosing and monitoring cancer. The methods comprise obtaining biological samples, extracting mitochondrial DNA (mtDNA) from the samples, quantifying mitochondrial DNA mutation in the sample and comparing the level of mtDNA mutation with a reference value. The methods of the invention may also be effective in screening for new therapeutic agents and treatment regimes, and may also be useful for monitoring the response of a subject to a preventative or therapeutic treatment.

Claim (Index 6):
The method of  claim 5 , wherein step (b) is conducted using real-time PCR.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 91.0
- Lexical Diversity: 1.69231
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15470175', '14470627', '11975390', '14627755', '13260497']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6619960021512882
- 35 USC 102 Novelty (BERT): 0.5446323388768917
- Combined Prediction Score: 0.6502596358238485
- Mean Citation Score: 362.00128
- Max Citation Score: 439.74933
- Similarity Product: 261.7343725042284

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test